Table 2.
Socio-demographic, clinical and baseline characteristics of patients in the Australian and Hong Kong sample (n = 74)
| Characteristics | Australian sample (n = 32) | Hong Kong sample (n = 42) | ||||
|---|---|---|---|---|---|---|
| All participants (n = 32) | Intervention (n = 17) | Control (n = 15) | All participants (n = 42) | Intervention (n = 17) | Control (n = 25) | |
|
Age (years), mean (SD) range |
63.7 (14.7) (28–86) |
64.6 (15.1) (42–85) |
62.7 (14.7) (28–86) |
72.4 (14) (35–95) |
69.8 (14) (35–89) |
74.2 (16) (43–95) |
|
BMI (kg/m2), mean (SD) range |
26.1 (7.0) (17.6–50.8) |
24.4 (3.9) (17.6–31.2) |
27.8 (9.0) (18.1–50.8) |
19.7 (3.5) (14.5–28.2) |
19.9 (3.3) (14.5–28.2) |
19.6 (3.6) (15.1–26.4) |
| Gender | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) |
| Female | 16 (50) | 8 (47) | 8 (53) | 26 (61.9) | 11 (64.7) | 15 (60) |
| Male | 16 (50) | 9 (53) | 7 (47) | 16 (38.1) | 6 (35.3) | 10 (40) |
| Primary cancer type | ||||||
| Gastrointestinal | 8 (25) | 2 (12) | 6 (40) | 20 (47.6) | 9 (53.1) | 11 (44) |
| Gynaecological | 3 (9) | 1 (6) | 2 (13) | 3 (7.1) | 1 (5.9) | 2 (8) |
| Lung | 2 (6) | 2 (12) | 0 (0) | 12 (28.6) | 4 (23.5) | 8 (32) |
| Skin | 4 (13) | 3 (18) | 1 (7) | – | – | – |
| Urological | 12 (38) | 8 (47) | 4 (27) | 5 (11.9) | 3 (17.6) | 2 (8) |
| Other (e.g. breast, thyroid, unknown primary) | 3 (9) | 1 (6) | 2 (13) | 2 (4.8) | 0 | 2 (8) |
|
Charlson Comorbidity Index Score, mean (SD) range |
6.1 (1.3) (2–8) |
5.9 (1.6) (2–8) |
6.3 (0.6) (6–8) |
– | – | – |
| Nutritional symptoms | ||||||
| No appetite | 11 (38) | 5 (33) | 6 (48) | 30 (71.4) | 10 (58.8) | 20 (66.7) |
| Feeling full quickly | 13 (45) | 9 (60) | 4 (29) | 16 (38.1) | 5 (29.4) | 11 (44) |
| Dry month | 3 (10) | 1 (7) | 2 (14) | 16 (38.1) | 6 (35.3) | 10 (62.5) |
| Things taste funny or have no taste | 7 (24) | 4 (27) | 3 (21) | 13 (31) | 4 (23.5) | 9 (36) |
| Smell bothers me | 2 (7) | 2 (13)* | 0 (0)* | 9 (21.4) | 3 (17.6) | 6 (24) |
| Nausea | 5 (17) | 5 (33) | 0 (0) | 8 (19) | 1 (5.9) | 7 (28) |
| Pain | 6 (21) | 3 (20) | 3 (21) | 5 (11.9) | 2 (11.8) | 3 (12) |
| Constipation | 7 (24) | 4 (27) | 3 (21) | 4 (9.5) | 3 (17.6) | 1 (4) |
| Diarrhoea | 3 (10) | 2 (13) | 1 (7) | |||
| Problems with swallowing | 2 (7) | 1 (7) | 1 (1) | 4 (9.5) | 3 (17.6) | 1 (4) |
| Mouth sores | 1 (3) | 0 (0) | 1 (7) | |||
| Vomiting | 2 (7) | 2 (13) | 0 (0) | 3 (7.1) | 1 (5.9) | 2 (8) |
| PG-SGA-SF total score, mean (SD) range |
8.0 (4.0) (1–17) |
8 (4) (1–15) |
8 (4) (1–17) |
10.2 (4.3) (1–19) |
9.8 (4.6) (2–19) |
10.6 (4.1) (1–19) |
| Eating-related distress (single item score), mean (SD) range |
3.1 (2.9) (0–10) |
3 (3) (0–8) |
3 (3) (0–10) |
3 (3.1) (0–8) |
2.6 (3.3) (0–8) |
3.2 (3) (0–8) |
|
Eating-related enjoyment (single item score), mean (SD) range |
3.8 (3.2) (0–9) |
5 (3) (0–9) |
3 (3) (0–8) |
6.8 (3.2) (0–8) |
7.7 (2.9) (0–8) |
6.3 (3.4) (0–8) |
|
FAACT total score, mean (SD) range |
102.0 (18.8) (60.3–140.0) |
96.66 (22.4) (60.3–140.0) |
108.2 (11.4) (90.0–127.0) |
95.9 (13.6) (65.7–121) |
101.6 (15.7)* (74–121) |
92.0 (10.5)* (66–114) |
|
FAACT cachexia subscale, mean (SD) range |
30.3 (8.0) (20.0–46.0) |
29.01 (7.7) (20.0–46.0) |
31.69 (8.3) (21.0–45.8) |
31 (5.6) (21–42) |
32.4 (5.4) (25–42) |
30.0 (5.6) (21–40) |
*P < 0.05